Description
Tadalafil is a phosphodiesterase (PDE5) inhibitor that leads to an increase in the cGMP levels in the smooth muscle cells lining the blood vessels. This action relaxes blood vessels and allows more blood flow. The research on Tadanafil has demonstrated its efficacy and safety in the treatment of various medical conditions such as erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). There is also ongoing research exploring its potential use in lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), as an adjunct therapy for infertility in men with ED and oligospermia, and in other areas.